Celldex Therapeutics, Inc. (CLDX) vs Nurix Therapeutics, Inc. (NRIX)
Celldex Therapeutics, Inc. and Nurix Therapeutics, Inc. are both Biotechnology companies. Celldex Therapeutics, Inc. and Nurix Therapeutics, Inc. are of similar size ($2.5B and $2.5B). Nurix Therapeutics, Inc. grew revenue faster over the last twelve months: −58.4% against −88.3%. Nurix Therapeutics, Inc. has the higher net margin (−928.4% vs −33,883.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Nurix Therapeutics, Inc. leads on 9 and Celldex Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | CLDX | NRIX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (36,733.82%) | (982.37%) | 0.00% |
| Net margin | (33,883.77%) | (928.44%) | 0.00% |
| Free cash flow margin | (27,294.81%) | (828.28%) | 0.00% |
| Return on equity | (43.88%) | (80.30%) | (57.72%) |
| Return on assets | (40.76%) | (60.57%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack